Hypothalamic-pituitary-adrenal axis function in chronic schizophrenia: association with clinical features

Area of Science:

• Neuroscience
• Psychiatry
• Endocrinology

Background:

• The hypothalamic-pituitary-adrenal (HPA) axis plays a crucial role in the stress response.
• Chronic schizophrenia is a complex psychiatric disorder with potential neuroendocrine involvement.
• Previous research suggests HPA axis dysregulation in various mental health conditions.

Purpose of the Study:

• To investigate the function of the HPA axis in chronic schizophrenia patients.
• To explore the association between HPA axis activity and clinical features, particularly negative symptoms.
• To identify potential biomarkers for HPA axis dysfunction in schizophrenia.

Main Methods:

• Salivary cortisol levels were measured to assess diurnal variation.
• The dexamethasone suppression test (DST) was performed using saliva samples.
• Patients were assessed for clinical symptoms, including negative symptoms and anxiety levels.
• Schizophrenia subtypes (e.g., disorganized type) were considered in the analysis.

Main Results:

• Abnormal diurnal cortisol variation was observed in 20 out of 33 chronic schizophrenics.
• Patients with abnormal diurnal cortisol showed higher scores for negative symptoms.
• DST nonsuppression occurred in 13 out of 34 patients, associated with disorganized type and lower anxiety.
• A subgroup with both abnormal diurnal variation and DST nonsuppression exhibited more severe negative symptoms and disorganized type schizophrenia.

Conclusions:

• A subset of chronic schizophrenia patients may experience HPA axis functional disturbances.
• These HPA axis abnormalities are potentially linked to more severe negative symptoms and specific clinical presentations.
• The findings suggest HPA axis function as a potential area for further investigation in schizophrenia pathophysiology and treatment.